Shilajit During Pregnancy & Breastfeeding: What the Medical Evidence Actually Says

Shilajit is one of the most researched adaptogens for energy, vitality, and mitochondrial support — but pregnancy and breastfeeding represent a category where the usual supplement analysis does not apply. The normal framework of weighing benefits against a known risk profile breaks down when there is simply no human clinical data for the population in question.

For shilajit specifically, that data gap is total. No peer-reviewed clinical trial has enrolled pregnant or breastfeeding women to study shilajit's effects, safety, or dosing. This is not an oversight — it reflects both the ethical difficulty of running supplement trials in pregnant populations and the relative youth of the modern shilajit research literature. The result is that institutions like Memorial Sloan Kettering Cancer Center and the National Center for Complementary and Integrative Health can only say: we don't have the data, and in the absence of data, avoid it.

This guide covers what MSK and the NCCIH actually say, why heavy metals make this concern more serious than it would be for most supplement categories, what to know about fulvic acid as a proposed alternative, and what the honest answer is for expecting and nursing mothers. The CTAs at the bottom of this page are framed specifically for after pregnancy and breastfeeding — they are not recommendations for use during these periods.

Memorial Sloan Kettering Cancer Center maintains one of the most widely cited independent databases for evaluating herbs and supplements — their Integrative Medicine program's herb and supplement database is written for clinicians and patients alike and is regularly updated as new evidence emerges. When MSK flags a supplement as contraindicated in a specific population, those flagged populations have reason to pay attention.

MSK's documented position on shilajit and pregnancy is clear: insufficient safety data exists for use during pregnancy and breastfeeding, and avoidance is the appropriate recommendation until that data exists. Their specific concerns for these populations center on two issues:

The National Center for Complementary and Integrative Health — part of the National Institutes of Health — maintains its own evidence-based assessments of complementary health approaches. The NCCIH's position on shilajit aligns with MSK's: insufficient evidence to establish safety during pregnancy or breastfeeding, and a recommendation to consult a healthcare provider before use.

The NCCIH also notes that shilajit has not been studied adequately in humans for any indication, let alone in the specific context of pregnancy. Their guidance for pregnant and nursing women considering herbal supplements is consistent across most supplement categories: unless a supplement has well-established safety data for these populations (as iron, folate, and prenatal vitamins do), the default is caution.

For most healthy adults, the primary safety concern with shilajit is buying a product from an unverified brand that hasn't been tested for heavy metals contamination. Brands with full-panel COA data from accredited labs — showing lead, mercury, arsenic, and cadmium within FDA dietary supplement limits — address this risk directly.

During pregnancy, that calculus changes. Pregnant women have heightened sensitivity to heavy metal exposure — not because the limits are higher, but because the fetus is far more vulnerable than an adult to trace heavy metal exposure:

This doesn't mean that a pregnant woman who took one serving of a COA-verified shilajit product has caused harm. The trace amounts in verified products at standard doses are small. But it does mean the risk calculus is fundamentally different during pregnancy — there is no established safe level of lead or mercury for fetal development, while there is a defined FDA limit for healthy adults.

Even brands with clean COA data carry trace amounts of heavy metals — that's what "within FDA limits" means. The distinction between verified and unverified shilajit matters most during pregnancy because unverified products may contain metals at concentrations significantly above what clean-tested brands show. For the full side-by-side heavy metals data across the top brands, see our complete heavy metals comparison →

Some pregnant women considering shilajit for its mineral-transport and energy properties look to standalone fulvic acid supplements as an alternative — the reasoning being that purified fulvic acid isolates might be safer than full-spectrum shilajit resin.

The same precautionary reasoning applies. Standalone fulvic acid supplements also lack human clinical safety data during pregnancy. Purified fulvic acid doesn't carry the same heavy metals profile as raw shilajit, but the fundamental issue is the same: no clinical trials have enrolled pregnant women to study fulvic acid safety or dosing, and the effects of fulvic acid compounds on fetal development, placental transport, or breast milk composition are unstudied.

The minerals that fulvic acid enhances absorption of — including iron — are already carefully managed during pregnancy through established prenatal supplementation protocols. Adding an uncharacterized absorption enhancer to a pregnancy supplement regimen introduces uncertainty that is difficult to justify without supporting evidence. For more on how shilajit and fulvic acid compare as supplements generally, see our guide on shilajit vs standalone fulvic acid supplements →

No peer-reviewed human clinical trial has studied shilajit use during pregnancy or breastfeeding. The absence of evidence is not evidence of safety — it is a knowledge gap, and in medicine, knowledge gaps in vulnerable populations are filled with precaution, not assumptions of harmlessness.

The medical consensus from Memorial Sloan Kettering, the NCCIH, and most integrative medicine practitioners is consistent: avoid shilajit during pregnancy and while breastfeeding. This is a standard precautionary position grounded in the absence of safety data and compounded by shilajit's documented heavy metals profile — trace metals that are meaningful for adult risk calculus but potentially more significant for fetal development.

If you are currently pregnant and were taking shilajit before you knew you were pregnant, one or a few servings of a verified, COA-tested product is unlikely to cause harm — the trace heavy metal doses in quality products are small. But this is not a reason to continue. Consult your OB-GYN, disclose what you were taking, and stop until after breastfeeding is complete.